Chicago Equity Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

Chicago Equity Partners’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$216K	Sell	29,830 -52,320	-64%	-$388K	0.02%	589
2019 Q4	$725K	Sell	82,150 -48,720	-37%	-$365K	0.04%	549
2019 Q3	$797K	Buy	+130,870	New	+$736K	0.04%	561
2016 Q3	–	Sell	-154,800	Closed	-$1.48M	–	802
2016 Q2	$1.48M	Sell	154,800 -1,820	-1%	-$19.8K	0.04%	326
2016 Q1	$2.2M	Buy	156,620 +910	+0.6%	+$9.42K	0.06%	247
2015 Q4	$1.69M	Buy	155,710 +82,490	+113%	+$746K	0.04%	281
2015 Q3	$499K	Buy	+73,220	New	+$567K	0.01%	471

Other funds holding NPTN

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chicago Equity Partners's NPTN Position: Q1 2020 in Review

Chicago Equity Partners reduced its NEOPHOTONICS CORP (NPTN) stake by 64% in Q1 2020, selling an estimated $388K and leaving 29,830 shares worth $216K. The position accounts for 0.02% of the portfolio, ranked #589.

Chicago Equity Partners first reported a position in NPTN in Q3 2015 and has held it in 7 quarters since. The position peaked at $2.2M in Q1 2016. 135 funds tracked by Wall St. Rank hold NPTN as of Q1 2020.

Chicago Equity Partners held 29,830 shares of NEOPHOTONICS CORP worth $216K as of Q1 2020.
Chicago Equity Partners sold 52,320 NEOPHOTONICS CORP shares in Q1 2020, an estimated $388K.
NEOPHOTONICS CORP made up 0.02% of Chicago Equity Partners's portfolio in Q1 2020, its #589 holding.
Chicago Equity Partners first reported a position in NEOPHOTONICS CORP in Q3 2015 and has held it in 7 quarters since.
Chicago Equity Partners's NEOPHOTONICS CORP position peaked at $2.2M in Q1 2016.
135 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.